Dexcom, Inc. (DXCM) fundamentals from SEC filings — revenue $4.7B, net margin 17.9%, diluted EPS $2.09 in FY2025. Revenue, margins, EPS and free cash flow, year by year.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $2.4B | $2.9B | $3.6B | $4.0B | $4.7B |
| Net income | $216.9M | $341.2M | $541.5M | $576.2M | $836.3M |
| Net margin | 8.9% | 11.7% | 14.9% | 14.3% | 17.9% |
| Diluted EPS | $0.53 | $0.82 | $1.30 | $1.42 | $2.09 |
| Free cash flow | $53.3M | $304.7M | $511.9M | $630.7M | $1.1B |
Figures are as reported to the SEC (EDGAR companyfacts), in the filer's own fiscal years.
Sign in to PortfolioX for the full analysis — ten years of history, segment and geographic breakdowns, valuation multiples, analyst estimates and filings. · PortfolioX home